Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Laura Taraboanta"'
Autor:
Jacqueline Lutz, Emanuela Offidani, Laura Taraboanta, Shaheen E. Lakhan, Timothy R. Campellone
Publikováno v:
Frontiers in Digital Health, Vol 4 (2022)
Digital therapeutics (DTx) are software programs that treat a disease or condition. Increasingly, DTx are part of medical care, and in the US healthcare system they are regulated by the FDA as Software as a Medical Device (SaMD). Randomized controlle
Externí odkaz:
https://doaj.org/article/0690029667b347abbf4f69bbcee40517
Autor:
Laura Taraboanta
Publikováno v:
JMIRx Med, Vol 2, Iss 4, p e34608 (2021)
Externí odkaz:
https://doaj.org/article/64f55b8235d047718e2f83b885146ad2
Autor:
Laura Taraboanta
Publikováno v:
JMIRx Med, Vol 2, Iss 4, p e34113 (2021)
Externí odkaz:
https://doaj.org/article/8dcebe3dcdd742eab60d79c28f6089ab
Autor:
Michelle Braley, Jordyn Sims Pierce, Sadhvi Saxena, Emily De Oliveira, Laura Taraboanta, Veera Anantha, Shaheen E. Lakhan, Swathi Kiran
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Background: Post-stroke aphasia is a chronic condition that impacts people's daily functioning and communication for many years after a stroke. Even though these individuals require sustained rehabilitation, they face extra burdens to access care due
Externí odkaz:
https://doaj.org/article/d53e1c7b798d47ae9bf883432f3cd272
Autor:
Cassandra Snipes, Alexander Kuka, Olya Besedina, Laura Taraboanta, Brendan Hare, Alankar Gupta, Shaheen Lakhan
Publikováno v:
Wednesday, April 26.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4ecad0314be7c81875b2ca785783899
https://doi.org/10.1212/wnl.0000000000202540
https://doi.org/10.1212/wnl.0000000000202540
Autor:
Jacqueline Lutz, Emanuela Offidani, Laura Taraboanta, Shaheen E. Lakhan, Timothy R. Campellone
Publikováno v:
Frontiers in digital health. 4
Digital therapeutics (DTx) are software programs that treat a disease or condition. Increasingly, DTx are part of medical care, and in the US healthcare system they are regulated by the FDA as Software as a Medical Device (SaMD). Randomized controlle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b47813a1357769de12ef8a1fd0e18d4d
https://pubmed.ncbi.nlm.nih.gov/36060538
https://pubmed.ncbi.nlm.nih.gov/36060538
Autor:
Laura Taraboanta
UNSTRUCTURED This is a peer review report.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e6c0330abba9d89fdfcd23d256ae32e
https://doi.org/10.2196/preprints.34608
https://doi.org/10.2196/preprints.34608
Autor:
Laura Taraboanta
UNSTRUCTURED This is a peer review report for ms#32336.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e2c5ac773be12c3b3db851a82fb131c
https://doi.org/10.2196/preprints.34113
https://doi.org/10.2196/preprints.34113
Autor:
Gary E. Landreth, Rebecca Skerrett, Brad T. Casali, Laura Taraboanta, Mateus Paquesse Pellegrino
Publikováno v:
The Journal of biological chemistry. 290(35)
Alzheimer disease (AD) is characterized by the extracellular accumulation of amyloid β (Aβ), which is accompanied by a robust inflammatory response in the brain. Both of these pathogenic processes are regulated by nuclear receptors, including the l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9344ed6da08357c3f009613f242c346
https://pubmed.ncbi.nlm.nih.gov/26163517
https://pubmed.ncbi.nlm.nih.gov/26163517